Literature DB >> 7909154

Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.

T Hasebe1, K Mukai, N Yamaguchi, K Ishihara, A Kaneko, Y Takasaki, Y Shimosato.   

Abstract

Thirteen cases of sebaceous gland carcinoma and 10 cases of sweat gland carcinoma were studied using immunohistochemical staining for proliferating cell nuclear antigen (PCNA), c-erbB-2, and p53 to examine correlations among them, and to determine the best predictor of patient prognosis. Many sebaceous gland carcinomas and sweat gland carcinomas showed nuclear accumulation of p53, and patients with tumors showing a PCNA index (percentage of nuclei stained for PCNA) higher than 20%, and a p53 index (percentage of nuclei stained for p53) higher than 10% had short survival. Sebaceous gland carcinomas and sweat gland carcinomas showing c-erbB-2 expression had high PCNA (> 20%) and p53 (> 10%) indices, and were associated with poor prognosis. Histologically, sebaceous gland carcinomas showing a high degree of differentiation and severe nucleolar atypia had high PCNA and p53 indices. A growth pattern of small solid nests and strands, a low degree of differentiation, and the presence of lymphatic permeation in sweat gland carcinoma were often associated with high PCNA and p53 indices. These results suggest that nuclear accumulation of p53 plays an important role in the development of sebaceous gland carcinoma and sweat gland carcinoma. Assessment of PCNA and p53 indices together was very useful for prognostication of patient outcome, using cut-off values of 20% and 10%, respectively, to separate good prognosis from poor. Differentiation of sebaceous gland carcinoma, and c-erbB-2 expression by sweat gland carcinoma were significant independent prognostic indicators.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909154

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  9 in total

1.  Sebaceous cell carcinoma of scalp - a rare presentation.

Authors:  Venkata Murali Krishna Bhavarajua; S Ejaz Shamim; V R Naik; Shamsol Shaari
Journal:  Malays J Med Sci       Date:  2007-01

Review 2.  Sweat gland progenitors in development, homeostasis, and wound repair.

Authors:  Catherine Lu; Elaine Fuchs
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

3.  Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.

Authors:  Bin Li; Ningdong Li; Guangyin Cheng; Xianli Sun; Xiaolin Xu; Jitong Shi; Liaoqing Li; Changxi Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-25       Impact factor: 3.117

Review 4.  Role of mucins in the skin during benign and malignant conditions.

Authors:  Subhankar Chakraborty; Neelima Bonthu; Benjamin J Swanson; Surinder K Batra
Journal:  Cancer Lett       Date:  2010-12-13       Impact factor: 8.679

5.  Immunohistochemical characterization of sebaceous epithelioma in two dogs.

Authors:  J S Yoon; J Park
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

6.  A sweat-gland tumor metastasizing to the axilla: report of a case.

Authors:  K Yamazaki; T Ishida; K Ondo; K Yamamoto; T Odashiro; G Saito; A Kido; Y Sasaki; H Yukaya; K Sugio; K Sugimachi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Authors:  Emilie Lanoy; Graça M Dores; Margaret M Madeleine; Jorge R Toro; Joseph F Fraumeni; Eric A Engels
Journal:  AIDS       Date:  2009-01-28       Impact factor: 4.177

8.  Sebaceous carcinoma of the parotid gland: a case report.

Authors:  Yohei Takada; Kohei Kawamoto; Susumu Baba; Tomoko Takada; Toshiya Inoue; Koichi Tomoda
Journal:  Case Rep Oncol       Date:  2015-02-21

9.  c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis.

Authors:  Denny L Cottle; Kai Kretzschmar; Pawel J Schweiger; Sven R Quist; Harald P Gollnick; Ken Natsuga; Satoru Aoyagi; Fiona M Watt
Journal:  Cell Rep       Date:  2013-02-09       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.